Monica Jane Barratt

Monica Jane Barratt

Auto-generated profile, based on publicly available information

Monica Jane Barratt

Curtin University

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

12 February 2014 in Addiction
Verified
Journal Article
Closed access
PDF file
MBMonica J. Barratt
Monica J. Barratt
JFJason Ferris
Jason Ferris
AWAdam R. Winstock
Adam R. Winstock

14 April 2014 in Field Methods
Verified
Journal Article
Closed access
MBMonica J. Barratt
Monica J. Barratt
JFJason Ferris
Jason Ferris
SLSimon Lenton
Simon Lenton
Online purposive samples have unknown biases and may not strictly be used to make inferences about wider populations, yet such inferences continue to occur. We compared the demographic and drug use characteristics of Australian ecstasy users from a probability (National Drug Strategy Household Survey, n = 726) and purposive sample (online survey conducted as part of a mixed-methods study of online drug discussion, n = 753) using nonparametric (bootstrap) and meta-analysis techniques. We found significant differences in demographics and drug use prevalence. Ideally, online purposive samples of hidden populations should be interpreted in conjunction with probability samples and ethnographic fieldwork.

8 February 2012 in Addiction
Verified
Journal Article
Open access
PDF file
MBMonica J. Barratt
Monica J. Barratt
Click on the article title to read more.

1 September 2016 in International Journal of Drug Policy
Verified
Journal Article
Closed access
MBMonica J. Barratt
Monica J. Barratt
JAJudith Aldridge
Judith Aldridge

9 October 2012 in Drug and Alcohol Review
Verified
Journal Article
Open access
PDF file
MBMonica J. Barratt
Monica J. Barratt
VCVince Cakic
Vince Cakic
SLSimon Lenton
Simon Lenton
Introduction and Aims: To assess the demographic profile, use patterns, market characteristics, reasons for first use and self‐reported harms associated with use of synthetic cannabinoids in Australia.Design and Methods: An online questionnaire was administered to a purposive sample of 316 Australian synthetic cannabinoid users [96% cannabis users, 77% male, median age 27 years, interquartile range (IQR) 23–34] who self‐reported demographic and drug use characteristics.Results: The median duration of synthetic cannabinoid use was 6 months (IQR 2–10), 35% reported use weekly or more often and 7% reported daily use. Reasons for first use included curiosity (50%), legality (39%), availability (23%), recreational effects (20%), therapeutic effects (9%), non‐detection in standard drug screening assays (8%) and to aid the reduction or cessation of cannabis use (5%). Users reported buying a median of 3 g (IQR 3–6) and paying a median of AU$60 (IQR 37–90). Most (68%) reported at least one side‐effect during their last session of use, including decreased motor co‐ordination (39%), fast or irregular heartbeat (33%), dissociation (22%), dizziness (20%), paranoia (18%) and psychosis (4%). 4 respondents reported seeking help. A greater number of side‐effects were reported by males, those aged 18–25 years, water pipe (‘bong’) users and concurrent alcohol drinkers.Discussion and Conclusions: The sample reported first using synthetic cannabinoids due to curiosity, legality, availability, effects, non‐detection in drug testing and to reduce their cannabis use. Harms were widely reported yet help‐seeking was minimal. Inclusion of questions regarding synthetic cannabinoids in household surveys is warranted.